Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Therapeutics - Page 34

Therapeutics

COVID-19 vacation Destinations
Biotechnology | Cartoons - Original | COVID-19 | Diagnostics | Medicine | NIH | Non-Profit Research | Pharmaceutical | Therapeutics | U.S. Congress | Vaccine

COVID-19 vacation Destinations

Planning a Summer vacation? Where to go? How about going to one of those large events with tens…

Read More COVID-19 vacation DestinationsContinue

Moderna announced agreement with Taiwan for 20 million doses of Moderna’s COVID-19 Vaccine and variant booster
Biotechnology | COVID-19 | Infectious Disease | Life Science History | Therapeutics | Vaccine

Moderna announced agreement with Taiwan for 20 million doses of Moderna’s COVID-19 Vaccine and variant booster

On Jul. 22, 2021, Moderna announced a new supply agreement with Taiwan for 20 million doses of Moderna’s…

Read More Moderna announced agreement with Taiwan for 20 million doses of Moderna’s COVID-19 Vaccine and variant boosterContinue

CDC and Texas confirmed Monkeypox In U.S. traveler
Biotechnology | CDC | Diagnostics | Infectious Disease | Therapeutics

CDC and Texas confirmed Monkeypox In U.S. traveler

On Jul. 16, 2021, the U.S. Centers for Disease Control and Prevention (CDC) announced and the Texas Department…

Read More CDC and Texas confirmed Monkeypox In U.S. travelerContinue

Merck Announces FDA approval of VAXNEUVANCE  for prevention of invasive pneumococcal disease
Biotechnology | FDA | Medicine | Pharmaceutical | Therapeutics

Merck Announces FDA approval of VAXNEUVANCE for prevention of invasive pneumococcal disease

On Jul. 16, 2021, Merck announced the U.S. Food and Drug Administration (FDA) had approved VAXNEUVANCE (Pneumococcal 15-valent…

Read More Merck Announces FDA approval of VAXNEUVANCE for prevention of invasive pneumococcal diseaseContinue

Rapid decrease in lung cancer and melanoma deaths lead overall continued decline in cancer death rate
Biotechnology | Diagnostics | Disease | Oncology | Radiology | Therapeutics

Rapid decrease in lung cancer and melanoma deaths lead overall continued decline in cancer death rate

On Jul. 8, 2021, the National Institutes of Health (NIH) reported that the overall cancer death rates continue…

Read More Rapid decrease in lung cancer and melanoma deaths lead overall continued decline in cancer death rateContinue

Collaboration created world’s largest browsable resource linking rare protein-coding genetic variants to human disease
Biotechnology | Diagnostics | Disease | Therapeutics

Collaboration created world’s largest browsable resource linking rare protein-coding genetic variants to human disease

On Jul. 8, 2021, access to the world’s largest browsable resource linking rare protein-coding genetic variants to human…

Read More Collaboration created world’s largest browsable resource linking rare protein-coding genetic variants to human diseaseContinue

SIGA supplied TPOXX (Tecovirimat) as compassionate treatment for Monkeypox case in the UK
Biotechnology | Therapeutics

SIGA supplied TPOXX (Tecovirimat) as compassionate treatment for Monkeypox case in the UK

On Jun. 30, 2021, SIGA Technologies announced that it had provided TPOXX (tecovirimat) to Liverpool University Hospitals NHS…

Read More SIGA supplied TPOXX (Tecovirimat) as compassionate treatment for Monkeypox case in the UKContinue

COVID-19 PPE distribution
Biotechnology | Cartoons - Original | COVID-19 | Diagnostics | Genomics | Life Science History | Medicine | Therapeutics | U.S. Congress | Vaccine

COVID-19 PPE distribution

Cast of Characters: Jay Inslee, Governor, Washington | Gavin Newsom, Governor, California | Doug Ducey, Governor, Arizona |…

Read More COVID-19 PPE distributionContinue

Eisai and Biogen announced FDA granted Breakthrough Therapy Designation for Lecanemab for treatment of Alzheimer’s disease
Disease | FDA | Neurology | Therapeutics

Eisai and Biogen announced FDA granted Breakthrough Therapy Designation for Lecanemab for treatment of Alzheimer’s disease

On Jun. 23, 2021, Biogen and Eisai announced that the U.S. Food and Drug Administration (FDA) had granted…

Read More Eisai and Biogen announced FDA granted Breakthrough Therapy Designation for Lecanemab for treatment of Alzheimer’s diseaseContinue

Construction of the Biologics Manufacturing Centre in Montreal completed
Biotechnology | Therapeutics | Vaccine

Construction of the Biologics Manufacturing Centre in Montreal completed

On Jun. 22, 2021, the National Research Council of Canada (NRC) announced it had completed construction of the…

Read More Construction of the Biologics Manufacturing Centre in Montreal completedContinue

Gilead’s Veklury (Remdesivir) associated with reduction in mortality rate in hospitalized patients with COVID-19
Biotechnology | COVID-19 | Therapeutics

Gilead’s Veklury (Remdesivir) associated with reduction in mortality rate in hospitalized patients with COVID-19

On Jun. 21, 2021, Gilead Sciences announced positive data from three retrospective studies of the real-world treatment of…

Read More Gilead’s Veklury (Remdesivir) associated with reduction in mortality rate in hospitalized patients with COVID-19Continue

Tonix Pharmaceuticals announced program to develop TNX-102 SL for treatment of long COVID syndrome
Biotechnology | COVID-19 | Infectious Disease | Therapeutics | Vaccine

Tonix Pharmaceuticals announced program to develop TNX-102 SL for treatment of long COVID syndrome

On Jun. 21, 2021, Tonix Pharmaceuticals announced that it planned to develop TNX-102 SL (cyclobenzaprine HCl sublingual tablets)…

Read More Tonix Pharmaceuticals announced program to develop TNX-102 SL for treatment of long COVID syndromeContinue

Newly licensed U.S. manufacturing facility increased availability of Fluzone high-dose quadrivalent (influenza vaccine)
Biotechnology | Influenza | Therapeutics | Vaccine

Newly licensed U.S. manufacturing facility increased availability of Fluzone high-dose quadrivalent (influenza vaccine)

On Jun. 17, 2021, the U.S. Food and Drug Administration (FDA) Center for Biologics Evaluation and Research granted…

Read More Newly licensed U.S. manufacturing facility increased availability of Fluzone high-dose quadrivalent (influenza vaccine)Continue

REGEN-COV phase 3 RECOVERY trial met primary outcome, improving survival in Hospitalized COVID-19 patients
Biotechnology | COVID-19 | Disease | Therapeutics | Vaccine

REGEN-COV phase 3 RECOVERY trial met primary outcome, improving survival in Hospitalized COVID-19 patients

On Jun. 16, 2021, Regeneron announced positive results from the largest trial assessing any monoclonal antibody treatment in…

Read More REGEN-COV phase 3 RECOVERY trial met primary outcome, improving survival in Hospitalized COVID-19 patientsContinue

Moderna and Magenta partner to distribute Moderna’s COVID-19 vaccine in United Arab Emirates
Biotechnology | COVID-19 | Infectious Disease | Therapeutics | Vaccine

Moderna and Magenta partner to distribute Moderna’s COVID-19 vaccine in United Arab Emirates

On Jun. 15, 2021, Moderna and Magenta Investments, an industrial conglomerate in the United Arab Emirates (UAE), announced…

Read More Moderna and Magenta partner to distribute Moderna’s COVID-19 vaccine in United Arab EmiratesContinue

University of British Columbia researchers received the New Frontiers in Research Fund 2020 Exploration award
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Therapeutics | Vaccine

University of British Columbia researchers received the New Frontiers in Research Fund 2020 Exploration award

On Jun. 14, 2021, University of British Columbia researchers Dr. Jayachandran Kizhakkedathu, Dr. Caigan Du and Dr. Christopher…

Read More University of British Columbia researchers received the New Frontiers in Research Fund 2020 Exploration awardContinue

Cocrystal’s COVID-19 antiviral CDI-45205 shown to be active against SARS-CoV-2 and prominent SARS-CoV-2 variants
Biotechnology | COVID-19 | Pharmaceutical | Therapeutics

Cocrystal’s COVID-19 antiviral CDI-45205 shown to be active against SARS-CoV-2 and prominent SARS-CoV-2 variants

On Jun. 14, 2021, Cocrystal Pharma announced the selection of CDI-45205 as the lead compound for further development…

Read More Cocrystal’s COVID-19 antiviral CDI-45205 shown to be active against SARS-CoV-2 and prominent SARS-CoV-2 variantsContinue

Moderna and Tabuk Pharmaceuticals partnered to commercialize  COVID-19 Vaccine in Saudi Arabia
Biotechnology | COVID-19 | Therapeutics | Vaccine

Moderna and Tabuk Pharmaceuticals partnered to commercialize COVID-19 Vaccine in Saudi Arabia

On Jun. 11, 2021, Moderna and Tabuk Pharmaceutical announced an agreement to commercialize the Moderna COVID-19 Vaccine and…

Read More Moderna and Tabuk Pharmaceuticals partnered to commercialize COVID-19 Vaccine in Saudi ArabiaContinue

Senolytics reduced COVID-19 symptoms in preclinical studies
Biotechnology | Clinical Research | COVID-19 | Infectious Disease | Therapeutics | Veterinary

Senolytics reduced COVID-19 symptoms in preclinical studies

On Jun. 8, 2021, Mayo Clinic researchers and colleagues at the University of Minnesota showed that COVID-19 exacerbates…

Read More Senolytics reduced COVID-19 symptoms in preclinical studiesContinue

Twist Bioscience began shipping of synthetic RNA controls for Kappa (B.1.617.1) SARS-CoV-2 variants
Biotechnology | COVID-19 | Diagnostics | Therapeutics | Vaccine

Twist Bioscience began shipping of synthetic RNA controls for Kappa (B.1.617.1) SARS-CoV-2 variants

On Jun. 8, 2021, Twist Bioscience announced that it had started shipping its synthetic RNA reference controls for…

Read More Twist Bioscience began shipping of synthetic RNA controls for Kappa (B.1.617.1) SARS-CoV-2 variantsContinue

MediciNova initiated sheep study under BARDA to develop MN-166 (ibudilast) as countermeasure against chlorine
Biotechnology | Chemistry | Infectious Disease | Therapeutics

MediciNova initiated sheep study under BARDA to develop MN-166 (ibudilast) as countermeasure against chlorine

On Jun. 7, 2021, MediciNova announced it had initiated a sheep study to investigate MN-166 (ibudilast) in an…

Read More MediciNova initiated sheep study under BARDA to develop MN-166 (ibudilast) as countermeasure against chlorineContinue

FDA granted accelerated approval for ADUHELM as the first and only Alzheimer’s disease treatment
Biotechnology | Disease | FDA | Neurology | Therapeutics

FDA granted accelerated approval for ADUHELM as the first and only Alzheimer’s disease treatment

On Jun. 7, 2021, Biogen and Eisai announced that the U.S. Food and Drug Administration (FDA) had granted…

Read More FDA granted accelerated approval for ADUHELM as the first and only Alzheimer’s disease treatmentContinue

FDA authorized lower 1,200 mg intravenous and subcutaneous dose of REGEN-COV antibody cocktail to treat COVID-19 patients
Biotechnology | FDA | Therapeutics

FDA authorized lower 1,200 mg intravenous and subcutaneous dose of REGEN-COV antibody cocktail to treat COVID-19 patients

On Jun. 4, 2021, Regeneron announced the U.S. Food and Drug Administration (FDA) updated the Emergency Use Authorization…

Read More FDA authorized lower 1,200 mg intravenous and subcutaneous dose of REGEN-COV antibody cocktail to treat COVID-19 patientsContinue

CytoDyn received first order from Chiral Pharma for use of Leronlimab for COVID-19 patients in the Philippines
Biotechnology | COVID-19 | HIV | Infectious Disease | Therapeutics

CytoDyn received first order from Chiral Pharma for use of Leronlimab for COVID-19 patients in the Philippines

On Jun. 1, 2021, CytoDyn announced that Chiral Pharma in the Philippines placed its first purchase order for…

Read More CytoDyn received first order from Chiral Pharma for use of Leronlimab for COVID-19 patients in the PhilippinesContinue

HHS launched first venture capital partnership to develop transformative technologies to combat future pandemics
Biotechnology | COVID-19 | Infectious Disease | NIH | Therapeutics | Vaccine

HHS launched first venture capital partnership to develop transformative technologies to combat future pandemics

On Jun. 1, 2021, the U.S. Department of Health and Human Services (HHS) unveiled a new type of…

Read More HHS launched first venture capital partnership to develop transformative technologies to combat future pandemicsContinue

FDA approved LUMAKRAS for patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer
Biotechnology | Diagnostics | Disease | FDA | Oncology | Radiology | Therapeutics

FDA approved LUMAKRAS for patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer

On May 28, 2021, Amgen announced that the U.S. Food and Drug Administration (FDA) had approved LUMAKRAS (sotorasib)…

Read More FDA approved LUMAKRAS for patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancerContinue

Pfizer and BioNTech received first authorization in European Union for COVID-19 vaccine in adolescents
COVID-19 | Therapeutics | Vaccine

Pfizer and BioNTech received first authorization in European Union for COVID-19 vaccine in adolescents

On May 28, 2021, Pfizer and BioNTech announced that the Conditional Marketing Authorization for COMIRNATY in the European…

Read More Pfizer and BioNTech received first authorization in European Union for COVID-19 vaccine in adolescentsContinue

Patient enrollment reached 90 percent in Innovation Pharma’s phase 2 clinical trial of brilacidin for COVID-19
COVID-19 | Pharmaceutical | Therapeutics

Patient enrollment reached 90 percent in Innovation Pharma’s phase 2 clinical trial of brilacidin for COVID-19

On May 27, 2021, Innovation Pharma announced that patient enrollment in the Company’s 120-patient, Phase 2 clinical trial…

Read More Patient enrollment reached 90 percent in Innovation Pharma’s phase 2 clinical trial of brilacidin for COVID-19Continue

Seattle Children’s researchers discovered that functional COVID-19 antibodies are lost quickly after mild cases
Biotechnology | COVID-19 | Non-Profit Research | Therapeutics

Seattle Children’s researchers discovered that functional COVID-19 antibodies are lost quickly after mild cases

On May 27, 2021, Seattle Children’s researchers published a study that uncovered a deeper understanding of why people…

Read More Seattle Children’s researchers discovered that functional COVID-19 antibodies are lost quickly after mild casesContinue

NIAID scientists found that Salmonella use intestinal epithelial cells to colonize the gut
Biotechnology | Diagnostics | FDA | Infectious Disease | NIH | Therapeutics

NIAID scientists found that Salmonella use intestinal epithelial cells to colonize the gut

On May 26, 2021, National Institutes of Health (NIH) scientists reported that the immune system’s attempt to eliminate…

Read More NIAID scientists found that Salmonella use intestinal epithelial cells to colonize the gutContinue

Page navigation

Previous PagePrevious 1 … 32 33 34 35 36 … 116 Next PageNext
  • Categories
  • Timeline
  • Aesthetics
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cardiology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemistry
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • olfactory
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Quantum
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Banner Advertising

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search